Barclays
ATRC icon

Barclays’s AtriCure ATRC Stock Holding History

Barclays’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-95,700
Closed -$3.82M – 4862
2020
Q3 		$3.82M Buy
95,700
+92,700
+3,090% +$3.93M ﹤0.01% 1585
2020
Q2 		$135K Hold
3,000
– – ﹤0.01% 4336
2020
Q1 		$101K Buy
+3,000
New +$108K ﹤0.01% 4785

Other funds holding ATRC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Barclays's ATRC Position: Q2 2026 in Review

Barclays increased its AtriCure (ATRC) stake by 52% in Q2 2026, buying an estimated $266K and bringing the position to 27,582 shares worth $772K. The position accounts for ﹤0.01% of the portfolio, ranked #2948.

Barclays first reported a position in ATRC in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.44M in Q1 2020. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Barclays held 27,582 shares of AtriCure worth $772K as of Q2 2026.
  • Barclays bought 9,447 AtriCure shares in Q2 2026, an estimated $266K.
  • AtriCure made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #2948 holding.
  • Barclays first reported a position in AtriCure in Q2 2013 and has held it in 53 quarters since.
  • Barclays's AtriCure position peaked at $7.44M in Q1 2020.
  • 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.